bicalutamide and Low Bone Density

bicalutamide has been researched along with Low Bone Density in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carles Galceran, J; Celma Domenech, A; Lorente Garcia, D; Morote Robles, J; Placer Santos, J; Planas Morin, J; Regis, L; Salvador Lacambra, C; Trilla Herrera, E1
Mistry, R; Parr, NJ; Wadhwa, VK; Weston, R1
Broulik, PD; Stárka, L1

Other Studies

3 other study(ies) available for bicalutamide and Low Bone Density

ArticleYear
Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy.
    Rheumatology international, 2014, Volume: 34, Issue:10

    Topics: Aged; Aged, 80 and over; Alendronate; Androgen Antagonists; Anilides; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Diseases, Metabolic; Denosumab; Femur Neck; Humans; Leuprolide; Lumbar Vertebrae; Male; Nitriles; Osteoporosis; Prostatic Neoplasms; Radiography; Tosyl Compounds

2014
Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
    BJU international, 2009, Volume: 104, Issue:6

    Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Density; Bone Diseases, Metabolic; Calcium; Fractures, Bone; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Nitriles; Prospective Studies; Prostatic Neoplasms; Risk Factors; Time Factors; Tosyl Compounds; Vitamin D

2009
Effect of antiandrogens casodex and epitestosterone on bone composition in mice.
    Bone, 1997, Volume: 20, Issue:5

    Topics: Androgen Antagonists; Anilides; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Epitestosterone; Humans; Luteinizing Hormone; Male; Mice; Nitriles; Orchiectomy; Organ Size; Phosphates; Risk Factors; Seminal Vesicles; Testis; Testosterone; Tosyl Compounds

1997